Skip to main content

Chanakya

Kwick Forensic Solutions IPO

Published: 22 August 2026 | 7.00 AM
Last Updated: 22 August 2026 | 7.00 AM

IPO Snapshot

Particulars Details
Chanakya View 🟢 Apply
Overall Rating ⭐⭐⭐⭐☆ (4/5)
GMP Today Updated Daily
Issue Size Rs. 50.77 Crore
Fresh Issue Rs. 41.05 Crore
Offer for Sale Rs. 9.72 Crore
Price Band Rs. 85–Rs. 90
Lot Size 1,600 Shares
Minimum Retail Investment Rs. 2,88,000 for 3,200 Shares
IPO Opens 27 August 2026
IPO Closes 31 August 2026
Allotment 1 September 2026
Listing 3 September 2026
Exchange BSE SME
Lead Manager Corporate Capital Ventures Pvt. Ltd.
Registrar Bigshare Services Pvt. Ltd.
Market Maker R.K. Stock Holding Pvt. Ltd.

Investor Decision Box

Question Chanakya View
Suitable for Listing Gain? 🟢 Yes, if GMP and demand remain healthy
Suitable for Long-Term? 🟡 Selective
Risk Level Medium to High
Business Quality ⭐⭐⭐⭐☆
Financial Strength ⭐⭐⭐⭐☆
Balance Sheet ⭐⭐⭐⭐⭐

👉 | IPO GMP|IPO Reviews |IPO Subscription|IPO Allotment

Chanakya View

Kwick Forensic Solutions operates in a specialised and relatively underpenetrated industry covering forensic science, cyber and digital forensics, DNA forensics, evidence management and law-enforcement solutions. Its customers include police departments, forensic laboratories, crime investigation departments, fingerprint bureaus, universities and police training institutions.

The company has reported impressive growth. Total income increased 63% to Rs. 105.80 crore in FY26, while profit after tax grew 58% to Rs. 13.51 crore. Its FY26 ROCE of 44.88% and RoNW of 32.62% indicate efficient capital utilisation. Borrowings were only Rs. 3.26 crore in FY25, while no borrowing amount has been reported for FY26.

At the upper price of Rs. 90, the post-issue P/E stands at 14.29 times. This appears reasonable considering the company’s growth, return ratios and niche business positioning. However, the small scale of operations, dependence on institutional and government orders, tender-based business and SME liquidity risks require attention.

The IPO appears suitable for investors with a higher risk appetite. The final decision should also consider GMP, subscription response—particularly QIB demand—and overall SME market sentiment.

Chanakya Recommendation: 🟢 Apply


About the Company

Incorporated in 2005, Kwick Forensic Solutions Limited provides forensic products, technologies and services across India. It initially operated in software development, 3D rendering, animation and simulation before expanding into forensic science and training technologies.

Its portfolio includes fingerprint and physical-evidence kits, Mobile Crime Scene Investigation Vehicles, evidence-collection equipment, cyber and digital-forensic tools, DNA forensic solutions, handheld devices and forensic-equipment rental services.

The company also provides installation, product demonstrations, operating training and post-delivery technical support. It sources specialised products from domestic and international original equipment manufacturers while developing certain devices and solutions through its in-house research and development capabilities.

Kwick Forensic holds multiple certifications, including ISO 9001:2015, ISO 14001:2015, ISO/IEC 20000-1:2018 and ISO/IEC 27001:2022. As of 31 July 2026, it had 33 payroll employees and 12 contractual employees.


Why This IPO Stands Out

✅ Operates in the specialised forensic science and law-enforcement segment.

✅ Diversified offerings across physical, digital, cyber and DNA forensics.

✅ FY26 revenue increased by 63%, indicating strong business momentum.

✅ FY26 PAT increased by 58% to Rs. 13.51 crore.

✅ Excellent ROCE of 44.88% and RoNW of 32.62%.

✅ Low reported borrowings and a healthy balance-sheet position.

✅ Reasonable post-issue valuation of 14.29 times earnings.


Key Risks

⚠ Dependence on government departments, forensic laboratories and tender-based orders may lead to uneven revenue recognition.

⚠ The company remains relatively small, with limited human resources and operational scale.

⚠ FY26 PAT margin declined marginally to 12.78% from 13.16%.

⚠ Nearly the entire fresh-issue utilisation is directed towards working capital rather than capacity creation.

⚠ Dependence on domestic and international OEM suppliers may create procurement and currency risks.

⚠ The minimum retail investment of Rs. 2,88,000 is substantial, while SME shares can face high volatility and limited liquidity.


Financial Snapshot (Rs. Crore)

Particulars FY26 FY25 FY24
Total Income 105.80 65.08 30.26
EBITDA 19.06 12.25 5.45
PAT 13.51 8.56 2.83
Net Worth 41.41 27.90 9.86
Borrowings Not Reported 3.26 3.24

Chanakya Interpretation

Kwick Forensic Solutions has delivered rapid financial expansion over the last three years. Total income more than tripled between FY24 and FY26, while PAT increased from Rs. 2.83 crore to Rs. 13.51 crore. EBITDA margin remained healthy at 18.03%, although it moderated slightly from FY25. High return ratios and low reported debt strengthen the investment case, but sustaining the recent growth rate will depend on new orders and efficient working-capital management.


Business Quality Score

Parameter Rating
Business Model ⭐⭐⭐⭐☆
Industry Outlook ⭐⭐⭐⭐☆
Financial Performance ⭐⭐⭐⭐⭐
Management ⭐⭐⭐⭐☆
Balance Sheet ⭐⭐⭐⭐⭐
Growth Potential ⭐⭐⭐⭐☆

IPO Proceeds & Why They Matter

PurposeAmount
Working Capital RequirementsRs. 31.42 Crore
General Corporate PurposesBalance Amount

Chanakya Interpretation

Kwick Forensic Solutions will use most of the fresh issue proceeds to strengthen working capital. The company supplies specialised products to police departments, forensic laboratories and other institutions, where tender execution, inventory procurement and payment collection can require significant funds.

Additional working capital should enable the company to accept larger orders, maintain adequate inventory and improve its execution capacity. However, the proceeds are not being used for a major manufacturing facility or transformational capacity expansion. Future growth will therefore depend on order inflows, execution and timely collection of receivables.


Business Outlook

Demand for forensic science, cybercrime investigation, digital evidence management and DNA-based investigation is expected to grow as law-enforcement agencies increasingly adopt technology-driven solutions.

Kwick Forensic’s diversified portfolio across physical, cyber, digital and DNA forensics gives it access to multiple segments. Its R&D capabilities, technical support and relationships with domestic and international manufacturers strengthen its competitive position.

However, revenue may remain uneven because government tenders can experience delays. The company must also continuously upgrade its products as forensic and cyber technologies evolve rapidly.


Strengths vs Concerns

👍 Strengths⚠ Concerns
Niche forensic-solutions businessDependence on government tenders
FY26 revenue growth of 63%Small operational scale
FY26 PAT growth of 58%Working capital-intensive model
ROCE of 44.88%Marginal decline in margins
Low reported borrowingsSupplier and technology dependence
Post-issue P/E of 14.29 timesSME liquidity and volatility risk

Who Should Apply?

Investor TypeSuitability
Listing-Gain Investors⭐⭐⭐⭐☆
Long-Term Investors⭐⭐⭐⭐☆
Conservative Investors⭐⭐☆☆☆
High-Risk Investors⭐⭐⭐⭐⭐

Chanakya Final Verdict

Kwick Forensic Solutions offers exposure to a specialised industry with promising long-term demand. Its rapid revenue and profit growth, high return ratios, low reported debt and reasonable valuation make the IPO attractive.

The post-issue P/E of 14.29 times appears comfortable considering FY26 growth. Nevertheless, investors must consider the company’s small size, dependence on tenders, working-capital requirements and possible fluctuations in yearly orders.

Chanakya Recommendation: 🟢 Apply

Listing-gain investors may apply if GMP and subscription demand remain healthy. Long-term investors may consider the IPO selectively and monitor order inflows, receivables and margins after listing.


Frequently Asked Questions

What is the Kwick Forensic Solutions IPO price band?

The price band is Rs. 85 to Rs. 90 per share.

What is the minimum investment in Kwick Forensic Solutions IPO?

The minimum individual investment is Rs. 2,88,000 for 3,200 shares.

When will Kwick Forensic Solutions IPO list?

Kwick Forensic Solutions is tentatively scheduled to list on BSE SME on 3 September 2026.

Who is the registrar and market maker of Kwick Forensic Solutions IPO?

Bigshare Services is the registrar, while R.K. Stock Holding is the market maker.

Should investors apply for Kwick Forensic Solutions IPO?

Chanakya’s recommendation is 🟢 Apply, subject to supportive GMP, subscription demand and SME market sentiment.

Leave a Reply

Your email address will not be published. Required fields are marked *